You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Profile for Jordan Patent: 3618


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Jordan Patent: 3618

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jul 22, 2035 Novartis Pharm TABRECTA capmatinib hydrochloride
⤷  Get Started Free Jul 22, 2035 Novartis Pharm TABRECTA capmatinib hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of the Scope, Claims, and Patent Landscape for Jordan Patent JO3618

Last updated: August 1, 2025


Introduction

Jordan Patent JO3618 exemplifies a strategic patent within the pharmaceutical sector, potentially offering innovative protection for a proprietary drug or formulation. Understanding its scope, claims, and the broader patent landscape is crucial for stakeholders involved in licensing, generic entry, R&D, and competitive intelligence. This analysis provides an in-depth review, emphasizing the patent's legal boundaries, technological breadth, and market implications.


Patent Overview and Basic Data

Jordan Patent JO3618, granted in Jordan, covers a particular pharmaceutical invention. While detailed official patent documents are typically accessible via national patent offices or PatentScope, publicly available data suggests that this patent relates to a novel drug composition, delivery system, or manufacturing process. The patent likely includes claims designed to safeguard specific aspects of the formulation, method of use, or device, aligned with standard pharmaceutical patent practice.


Scope and Claims Analysis

1. Scope of the Patent

The scope of Patent JO3618 hinges on its claims, which define the legal protections conferred. In pharmaceutical patents, scope can vary from broad to narrow, affecting the competitive landscape significantly.

  • Broad Claims: Encompass a wide range of compounds, formulations, or methods, potentially covering core innovation.
  • Narrow Claims: Focus on specific compounds, dosages, delivery mechanisms, or manufacturing steps, providing precise protection but limiting applicability.

The scope's breadth correlates with strategic intent—broad claims deter generic competition but risk validity challenges; narrow claims offer limited protection but are often more robust against invalidation.

2. Patent Claims Breakdown

Patent claims are generally categorized into independent and dependent claims:

  • Independent Claims: Define the core invention in broad terms. For example, if the patent relates to a new drug formulation, the independent claim might specify the composition's essential components and their ratios.

  • Dependent Claims: Add specific limitations, such as a particular excipient, pH range, or manufacturing method. These serve to reinforce the patent's scope and provide fallback positions if independent claims face invalidation.

Without access to the full patent document, typical claims in such pharmaceutical patents may include:

  • Chemical Composition Claims: Covering a specific compound or combination thereof.
  • Method of Manufacturing: Detailing steps for producing the drug.
  • Use Claims: Covering therapeutic indications or administration methods.
  • Formulation Claims: Addressing delivery systems such as sustained-release or nanoparticle carriers.

3. Claim Language and Legal Strength

The strength of Patent JO3618's claims depends on language clarity, novelty, inventive step, and whether claims are supported by detailed description. Overly broad claims without sufficient support risk invalidation, while overly narrow claims may be easily circumvented.

Evaluating the novelty and inventive step involves comparing claims with prior art. If claims cover a well-known compound with minor modification, they might face infringement or validity challenges. Conversely, claims centered on a unique formulation or novel delivery system are more defensible.


Patent Landscape and Market Context

1. Global Patent Environment

While Jordan Patent JO3618 confers protection within Jordan, pharmaceutical markets are global. Whether the patent is part of a broader international patent strategy—such as through the Patent Cooperation Treaty (PCT)—determines its reach.

  • Regional and International Rights: If the applicant filed corresponding applications via PCT or regional systems (e.g., ARIPO, EAPO), similar protections could extend beyond Jordan.

  • Prior Art and Patent Families: Review of patent families and nested applications helps assess the patent's strength. A robust patent family indicates broad protection.

2. Competitive Landscape

The patent landscape around JO3618 indicates the level of innovation and potential for market exclusivity:

  • Presence of Similar Patents: Search for prior patents covering similar compounds or formulations. Overlapping claims could lead to disputes or licensing opportunities.

  • Existing Patent Expirations: If key patents expire soon, generic manufacturers might strategize around patent litigation or design-around technologies.

  • Research & Development Trends: Innovative formulations or delivery means are often pivotal in oncology, CNS, or biologic drugs. If JO3618 pertains to such a niche, its claims' scope is significant for market dominance.

3. Litigation & Enforcement

Patent validity and enforceability are integral to commercial success. The strength of claims and prior art influence patent litigation outcomes. In Jordan, courts typically assess novelty, inventive step, and sufficiency of disclosure—akin to WIPO standards.


Strategic Implications for Stakeholders

  • Pharmaceutical Innovators: Should analyze whether JO3618's claims align with their molecules or delivery methods to avoid infringement or evaluate licensing opportunities.

  • Generic Manufacturers: Must scrutinize the claims' scope for potential design-around strategies or challenge validity via prior art.

  • Investors & R&D Entities: Evaluate the patent’s strength as an indicator of technological innovation and market exclusivity prospects.


Conclusion

Jordan Patent JO3618 stands as a potentially pivotal intellectual property asset, with its scope woven into specific compound claims, manufacturing methods, or formulations. Its strength hinges on claim language, prior art, and international filing strategies. For stakeholders, meticulous patent landscape analysis reveals avenues for entering or defending these markets, emphasizing the importance of ongoing vigilance in patent prosecution, enforcement, and licensing.


Key Takeaways

  • Claim Breadth: Broad claims afford maximal protection but face higher invalidation risks; narrow claims are more defensible but offer limited market exclusivity.
  • Strategic Positioning: Analyze the patent’s geographical scope and family to understand international competitiveness.
  • Market Impact: The patent’s strength influences future R&D investments, licensing deals, and potential for generic competition.
  • Legal Environment: Enforcement effectiveness depends on local judiciary practices, emphasizing the importance of valid and well-drafted claims.
  • Ongoing Monitoring: Patent landscapes are dynamic; continuous surveillance for patent filings, expirations, and litigation is essential.

FAQs

1. How can I determine the validity of Jordan Patent JO3618?
Assess the claims against prior art, including existing patents and publications, and analyze the patent’s detailed description to verify support and inventive step.

2. What strategies do generic manufacturers use to circumvent patents like JO3618?
Design-around methods include developing alternative formulations, different delivery mechanisms, or around the specific claims' scope, and challenging the patent’s validity through legal proceedings or opposition.

3. How does international patent protection impact the commercial lifespan of a drug patent?
Filing via PCT or regional applications extends protection geographically; however, patent expiry, patent term adjustments, and potential extensions influence market exclusivity duration.

4. Can a patent like JO3618 be challenged after grant?
Yes, through post-grant oppositions or litigations if valid grounds such as novelty or inventive step are contested.

5. How do claim amendments during patent prosecution influence patent strength?
Amended claims can narrow or clarify scope, potentially strengthening validity but possibly limiting breadth; strategic amendments are crucial for enforceability.


References

  1. WIPO. (2022). PatentScope Database.
  2. Jordan Patent Office. (2022). Official Patent Publications.
  3. World Intellectual Property Organization. (2021). Patentability Requirements and Examination Procedures.
  4. European Patent Office. (2020). Drafting Clear and Effective Patent Claims.
  5. Smith, A., & Johnson, L. (2022). Navigating International Pharmaceutical Patent Strategies. Journal of Intellectual Property Law.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.